Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous methylene blue for acute NAION
MOH_2025-10-05_014371Phase 2Not yet recruiting
- Sponsor
- ד"ר עומר ביאלר
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methylthioninium chloride in non-arteritic anterior ischemic optic neuropathy (NAION), sponsored by ד"ר עומר ביאלר. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
methylthioninium chloride
03
Conditions
non-arteritic anterior ischemic optic neuropathy (NAION)
Beyond the preview
Go deeper on MOH_2025-10-05_014371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2025-10-05_014371.